Novel Molecular Targets and Innovative Therapeutic Perspective in Medulloblastoma — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Novel Molecular Targets and Innovative Therapeutic Perspective in Medulloblastoma — Stella

Recruiting

Back to Medulloblastoma, Childhood trials

Early Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.

Trial locations(1 site)

Italy

Fondazione Policlinico Gemelli Irccs, Roma, ROMA

Key details

Phase

Very early testing

Sponsor

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Collaborators

University of Rome Tor Vergata, Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello

Enrollment target

~60 participants

Started

November 2024

Primary completion

August 2026

Age range

0 Years – 18 Years

Last updated May 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov